The clinical effects of vitamin E have been investigated in 7 cases (3 adolescents and 4 adults) of purpura due to vascular changes caused by infec tion, drugs or of unknown etiology. Marked clinical improvements were observed following the oral administration of vitamin E (400 to 600mg of a-tocopherol nicotinate per day) in all cases. Six out of 7 cases showed remarkable improve ment of petechiae following the vitamin E therapy alone.
Complete disappea rance of petechiae was observed following the administration of vitamin E for 5days in 2 cases, 14days in 4 cases and 21days in 1 case, along with the improvements of other clinical symptoms.
The antipurpuric action of vitamin E has been reported for experimentally produced pur puras caused by injecting dogs with stilbestrol (1) and for increased capillary fragility in rats due to X-ray irradiation (2) . Clinically, good effects from vitamin E therapy have been also reported in thrombocytopenic purpuras (1) and in patients with purpura associated with in creased capillary fragility (3, 4) . Although there have been few reports concerning the therapeu tic effects of vitamin E on patients with pur pura besides the aforementioned, it is of value to confirm the clinical effects of vitamin E in the treatment of Purpuras. This is a report on 7 cases of purpura due to vascular alterations in which vitamin E was tried as a treatment for purpura.
MATERIALS AND METHOD
Vitamin E therapy was tried in 7 cases of purpura due to vascular changes caused by infection, drugs or of unknown etiology, who These medicines were stopped on February 8 and vitamin E was started. After oral administration of 600mg of vitamin E per day for 14 days, most of the petechiae on all extremities disappeared and after 3 weeks of administration the petechiae disappeared com pletely.
Case 7. 54 years of age, businessman He had been diagnosed as having hyperten sion in early June, 1971, and received 0.8mg of reserpine, 100mg of hydralazine hydrochlo ride and 1.5g of clofibrate per day for about 2 months from his physician.
He developed extensive petechiae on the extensor surfaces of both arms and lower legs at the middle of August, 1971. He had no signs of infection prior to the onset of the petechiae. Reserpine, hydralazine hydrochloride and clofibrate were stopped on September 4, 1971 and he was given 20mg of carbazochrome sodium sulfate and 30 mg of phytonadione per day orally. The pete chiae persisted, and he came to us on September 9, 1971. Physical examination revealed nothing of significance other than extensive petechiae on all extremities.
Blood pressure was 140/ 102. No fever, epistaxis, gingival bleeding, skin eruptions, lymphadenopathy or joints symptoms were noted. There were no abnormalities in feces, urine and liver function tests. Vitamin 
